Provided by Tiger Trade Technology Pte. Ltd.

Arrowhead Pharmaceuticals

56.33
-0.6300-1.11%
Pre-market: 56.750.4200+0.75%08:27 EDT
Volume:6.22M
Turnover:349.67M
Market Cap:7.89B
PE:38.19
High:58.00
Open:56.79
Low:54.89
Close:56.96
52wk High:76.76
52wk Low:9.57
Shares:140.01M
Float Shares:120.00M
Volume Ratio:2.48
T/O Rate:5.18%
Dividend:- -
Dividend Rate:- -
EPS(TTM):1.48
EPS(LYR):-0.0122
ROE:75.50%
ROA:14.35%
PB:13.87
PE(LYR):-4,619.86

Loading ...

Arrowhead options imply 11.3% move in share price post-earnings

TIPRANKS
·
Nov 26, 2025

Stock Track | Arrowhead Pharmaceuticals Soars 5% on $200 Million Payment from Sarepta and Upcoming Earnings

Stock Track
·
Nov 26, 2025

Stock Track | Arrowhead Pharmaceuticals Soars 5.02% on $200 Million Milestone Payment from Sarepta

Stock Track
·
Nov 26, 2025

Arrowhead Pharmaceuticals (ARWR) Receives a Buy from B. Riley Securities

TIPRANKS
·
Nov 25, 2025

Top News Today/Canada: Barrick Makes a Deal With Mali

Dow Jones
·
Nov 25, 2025

Arrowhead Pharmaceuticals Earns $200 Million Milestone Payment from Sarepta Therapeutics

Reuters
·
Nov 24, 2025

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
Nov 24, 2025

Arrowhead Pharmaceuticals Is Maintained at Neutral by Goldman Sachs

Dow Jones
·
Nov 20, 2025

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
Nov 20, 2025

Arrowhead price target raised to $48 from $27 at Goldman Sachs

TIPRANKS
·
Nov 20, 2025

Arrowhead Pharmaceuticals Poised for Commercial Transition After First FDA Approval, RBC Says

MT Newswires Live
·
Nov 20, 2025

RBC Raises Price Target on Arrowhead Pharmaceuticals to $52 From $45, Keeps Outperform, Speculative Risk

MT Newswires Live
·
Nov 19, 2025

Arrowhead Pharmaceuticals Is Maintained at Overweight by Piper Sandler

Dow Jones
·
Nov 19, 2025

Arrowhead Pharmaceuticals (ARWR) Receives a Buy from RBC Capital

TIPRANKS
·
Nov 19, 2025

Arrowhead Pharmaceuticals: Hold Rating Amid Market Challenges and Future Opportunities

TIPRANKS
·
Nov 19, 2025

Arrowhead Pharmaceuticals : Piper Sandler Raises Target Price to $70 From $45

THOMSON REUTERS
·
Nov 19, 2025

U.S. RESEARCH ROUNDUP-Amgen, Crowdstrike, Micron Technology

Reuters
·
Nov 19, 2025

Arrowhead Pharmaceuticals’ REDEMPLO Approved by FDA

TIPRANKS
·
Nov 19, 2025

Sector Update: Health Care Stocks Higher Tuesday Afternoon

MT Newswires Live
·
Nov 19, 2025

Arrowhead Pharmaceuticals Says Wholesale Acquisition Cost Price of Redemplo Is $60,000

THOMSON REUTERS
·
Nov 19, 2025